{"id":6680,"date":"2021-06-15T16:03:52","date_gmt":"2021-06-15T14:03:52","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/06\/Eligo-Presents-Preclinical-Data-Demonstrating-for-the-First-Time-that-Gut-Microbiome-Modulation-via-Delivery-of-CRISPR-Nuclease-Impacts-Disease-Progression.pdf"},"modified":"2021-06-15T16:03:52","modified_gmt":"2021-06-15T14:03:52","slug":"eligo-presents-preclinical-data-demonstrating-for-the-first-time-that-gut-microbiome-modulation-via-delivery-of-crispr-nuclease-impacts-disease-progression","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/eligo-presents-preclinical-data-demonstrating-for-the-first-time-that-gut-microbiome-modulation-via-delivery-of-crispr-nuclease-impacts-disease-progression\/eligo-presents-preclinical-data-demonstrating-for-the-first-time-that-gut-microbiome-modulation-via-delivery-of-crispr-nuclease-impacts-disease-progression\/","title":{"rendered":"Eligo Presents Preclinical Data Demonstrating for the First Time that Gut Microbiome Modulation via Delivery of CRISPR Nuclease Impacts Disease Progression"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-6680","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n